Lineage Cell Therapeutics, Inc. (LCTX): Price and Financial Metrics
LCTX Price/Volume Stats
Current price | $0.69 | 52-week high | $1.61 |
Prev. close | $0.69 | 52-week low | $0.48 |
Day low | $0.66 | Volume | 800,700 |
Day high | $0.70 | Avg. volume | 2,045,957 |
50-day MA | $0.59 | Dividend yield | N/A |
200-day MA | $0.84 | Market Cap | 153.17M |
LCTX Stock Price Chart Interactive Chart >
Lineage Cell Therapeutics, Inc. (LCTX) Company Bio
Lineage Cell Therapeutics, Inc. operates as a biotechnology company. The Company offers cell-based therapies and gene marker-based molecular diagnostics for diseases and degenerative conditions. Lineage Cell Therapeutics serves patients in the United States.
LCTX Price Returns
1-mo | 20.76% |
3-mo | -20.18% |
6-mo | -21.65% |
1-year | -38.94% |
3-year | -56.05% |
5-year | N/A |
YTD | 37.31% |
2024 | -53.90% |
2023 | -6.84% |
2022 | -52.24% |
2021 | 39.20% |
2020 | 97.75% |
Loading social stream, please wait...